Results 1 to 10 of about 205,296 (406)
Radiation Oncology, 2020
Background The literature regarding pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy (IMRT) for esophageal cancer was lacking.
Tzu-Hui Pao+6 more
doaj +2 more sources
Background The literature regarding pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy (IMRT) for esophageal cancer was lacking.
Tzu-Hui Pao+6 more
doaj +2 more sources
Diagnosis and management of pericardial effusion [PDF]
Journal of Mind and Medical Sciences, 2020Pericardial effusion is a common pathology in clinical practice. The etiology of pericardial effusion is diverse, from infectious diseases, malignancies, autoimmune diseases, chronic renal failure, to drug-related or after an invasive cardiac ...
Maria Manea+3 more
doaj +3 more sources
Pericardial effusion under nivolumab: case-reports and review of the literature
Journal for ImmunoTherapy of Cancer, 2019Background Nivolumab, a programmed death-1 (PD-1) inhibitor, is an immune checkpoint inhibitor particularly used in the treatment of malignant melanoma, non-small cell lung cancer and renal cell carcinoma. Immune-related adverse events are frequent under
Saade Anastasia+7 more
doaj +2 more sources
Concurrent acute pancreatitis and pericardial effusion [PDF]
The Pan African Medical Journal, 2015While pleural effusion and ascites secondary to acute pancreatitis are common, clinically relevant pericardial effusion and cardiac tamponade are observed rarely.In a study by Pezzilli et al., pleural effusion was noted in 7 of the 21 patients with acute
Yusuf Kayar+6 more
doaj +5 more sources
Chronic massive pericardial effusion: a case report and literature review
Journal of International Medical Research, 2020Chronic massive pericardial effusion without cardiac tamponade is relatively rare. Nearly half of all patients with chronic large pericardial effusion are asymptomatic.
Ying-shuo Huang+2 more
doaj +2 more sources
Jornal Brasileiro de Pneumologia, 2021
E. Marchiori, B. Hochhegger, G. Zanetti
semanticscholar +4 more sources
E. Marchiori, B. Hochhegger, G. Zanetti
semanticscholar +4 more sources
Building Disease Detection Algorithms with Very Small Numbers of Positive Samples [PDF]
, 2018Although deep learning can provide promising results in medical image analysis, the lack of very large annotated datasets confines its full potential. Furthermore, limited positive samples also create unbalanced datasets which limit the true positive rates of trained models.
DJ Penny+5 more
arxiv +3 more sources
Frontiers in Oncology, 2019
Background: Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for previously treated non-small cell lung cancer.
Masahiro Yamasaki+11 more
doaj +2 more sources
Background: Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for previously treated non-small cell lung cancer.
Masahiro Yamasaki+11 more
doaj +2 more sources
Echocardiographic Evaluation of Pericardial Effusion and Cardiac Tamponade
Frontiers in Pediatrics, 2017Pericardial effusion (PEff) is defined by an increase in the physiological amount of fluid within the pericardial space. It can appear following different medical conditions, mainly related to inflammation and cardiac surgery.
Sergi Cesar, Joan Sanchez-de-toledo
exaly +2 more sources
Pericardial effusion in an Indian context: clinical insights and dynamics from a tertiary care centre [PDF]
BMC Cardiovascular DisordersBackground Pericardial effusion (PE) indicates the build-up of fluid within the pericardial sac, which encases the heart. The present study was undertaken to assess the clinical profile, etiology of pericardial effusion and to determine the correlation ...
Nafeez Javed Shaik+3 more
doaj +2 more sources